Brazilian Journal of Infectious Diseases

Papers
(The H4-Index of Brazilian Journal of Infectious Diseases is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil87
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines86
Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection83
Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil75
Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil52
Ivermectin: potential candidate for the treatment of Covid 1943
Molecular mechanisms of organ damage in sepsis: an overview37
Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge36
SARS-CoV-2 leading to acute pancreatitis: an unusual presentation35
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality35
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors34
High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil31
Is Mucormycosis an inevitable complication of Covid-19 in India?24
Calcineurin inhibitors revisited: A new paradigm for COVID-19?22
Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids22
SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients22
The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease22
Mobile genetic elements associated with carbapenemase genes in South American Enterobacterales20
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III19
0.038928985595703